Abstract
Pancreatic ribonuclease A (RNase A) has been shown to aggregate moderately and gradually at 65°C. Antibodies raised against the dodecapeptide KETAAAKFERQG corresponding to the N-terminal 1-12 amino acid residues of RNase A (Npep) as well as native RNase A were effective in lowering RNase A aggregation at 65°C. The antiRNase A antibodies were, however, more protective. The binding of antiNpep antibodies to the N-terminal region of RNase A may interfere with initiation of oligomerization of the enzyme and consequently its aggregation. The antiRNase A antibodies were presumably more effective in protecting RNase A against aggregation by binding to multiple epitopes of the enzyme including the N-terminal region and hence restricting the interaction of the monomers.
Keywords: ribonuclease A, antibodies, aggregation inhibition
Protein & Peptide Letters
Title: Inhibition of Pancreatic Ribonuclease A Aggregation by Antibodies Raised Against the Native Enzyme and Its N-Terminal Dodecapeptide
Volume: 13 Issue: 7
Author(s): Hina Younus, Renate Ulbrich-Hofmann and Mohammad Saleemuddin
Affiliation:
Keywords: ribonuclease A, antibodies, aggregation inhibition
Abstract: Pancreatic ribonuclease A (RNase A) has been shown to aggregate moderately and gradually at 65°C. Antibodies raised against the dodecapeptide KETAAAKFERQG corresponding to the N-terminal 1-12 amino acid residues of RNase A (Npep) as well as native RNase A were effective in lowering RNase A aggregation at 65°C. The antiRNase A antibodies were, however, more protective. The binding of antiNpep antibodies to the N-terminal region of RNase A may interfere with initiation of oligomerization of the enzyme and consequently its aggregation. The antiRNase A antibodies were presumably more effective in protecting RNase A against aggregation by binding to multiple epitopes of the enzyme including the N-terminal region and hence restricting the interaction of the monomers.
Export Options
About this article
Cite this article as:
Younus Hina, Ulbrich-Hofmann Renate and Saleemuddin Mohammad, Inhibition of Pancreatic Ribonuclease A Aggregation by Antibodies Raised Against the Native Enzyme and Its N-Terminal Dodecapeptide, Protein & Peptide Letters 2006; 13 (7) . https://dx.doi.org/10.2174/092986606777790629
DOI https://dx.doi.org/10.2174/092986606777790629 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Effect of Lithium on Neurocognitive Functioning
Current Alzheimer Research Changes of Gene Expression in the Developing Brain by Acute Ethanol Exposure
Current Psychopharmacology On the Existence of a Global Molecular Network Enmeshing the Whole Central Nervous System: Physiological and Pathological Implications
Current Protein & Peptide Science Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease
Current Pharmaceutical Design Non-invasive Cerebellar Stimulation in Cerebellar Disorders
CNS & Neurological Disorders - Drug Targets The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum- Induced Peripheral Neurotoxicity
Current Cancer Drug Targets Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Visualization of Brain Amyloid and Microglial Activation in Mouse Models of Alzheimers Disease
Current Alzheimer Research Computer Aided Drug Design: Success and Limitations
Current Pharmaceutical Design Cardio-Hepatic Metabolic Derangements and Valproic Acid
Current Clinical Pharmacology Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine
Reviews on Recent Clinical Trials A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
Current Pharmaceutical Design Mediterranean Diet and Risk of Dementia
Current Alzheimer Research Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
Coronaviruses The Many Faces of Aβ: Structures and Activity
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Trans-diagnostic Validation in Neuro-psychiatry: Towards Biological Signatures of Disease
Current Topics in Medicinal Chemistry Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor
Current Topics in Medicinal Chemistry Genetic Mapping of Pharmacogenetic Regulatory Variation
Current Pharmaceutical Design Pyrazolines: A Biological Review
Mini-Reviews in Medicinal Chemistry